AdvaMed

AdvaMed, or the Advanced Medical Technology Association, is an American medical device trade association, based in Washington, D.C. It is the largest medical device association in the world[1] with U.S. and international members who are medical technology companies (medical devices, diagnostic products, and health information systems) that collectively represents 80% of U.S. medical technology firms in the United States, that produce close to 90% of annual health care technology purchases in the United States and more than 40% globally.

AdvaMed
IndustryMedical Technology
HeadquartersWashington, D.C.
Key people
Scott Whitaker (CEO)
Nadim Yared (Board Chairman)
Websitewww.advamed.org/ 

Scott Whitaker is AdvaMed’s President and CEO,[2] and its current Board Chairman is Nadim Yared, also serves as President and CEO of CVRx, Inc.[3]

Policies

AdvaMed’s website states that the organization promotes competitive policies that foster the highest ethical standards, rapid product approvals, appropriate reimbursement, and access to international markets.[4]

The Innovation Agenda identifies five core policy pillars: improving the FDA’s regulatory processes, restructuring CMS’s coverage and payment processes, reforming the U.S. tax system to create a level playing field, improving access to international markets, and supporting the maintenance and growth of an R&D infrastructure.[5]

Medical Device Tax

AdvaMed has consistently and strongly opposed the 2.3 percent medical device excise tax imposed by the Affordable Care Act in 2013, stating that it harms job creation, deters medical innovation needed to save and improve patients’ lives, and inhibits economic growth.

In 2015, Congress temporarily suspended the medical device excise tax. While AdvaMed supported the suspension, the association continues to push for full and permanent repeal of the tax. Whitaker has stated that “It’s not enough to delay or further suspend this disruptive tax, even if for a longer period of time. It simply does not give industry the certainty and confidence it needs to make these critical long-term R&D investments. The time is now. We stand ready to help this administration, Congress, and the nation get Americans back on the job."[6]

In February 2017, AdvaMed released data from the U.S. Department of Commerce revealing that the U.S. medical technology industry saw its jobs ranks fall by nearly 29,000 while the medical device excise tax was in effect.[7]

gollark: Did you `systemctl enable` it?
gollark: There was a slight file descriptor leak.
gollark: Did you compile the latest version?
gollark: Very slight differences in function post-reboot I think.
gollark: I rebooted it slightly before rebooting osmarks.net a while ago.

References
  1. "Member Organizations | FDA Medical Device Industry Coalition". FMDIC. Retrieved June 25, 2018.
  2. "AdvaMed Names Scott Whitaker CEO and President". PRnewswire. February 18, 2016. Retrieved June 25, 2018.
  3. "Report: CVRx CEO Yared tapped for AdvaMed chairman". Mass Device. June 27, 2016. Retrieved June 25, 2018.
  4. "About AdvaMed". AdvaMed. Retrieved June 25, 2018.
  5. "Innovation Agenda". AdvaMed. Retrieved June 25, 2018.
  6. "Surveys Illustrate Positive Results of Device Tax Suspension". Your online source for medical device product information - Medical Product Outsourcing. January 10, 2017. Retrieved June 25, 2018.
  7. Arundhati Parmar (February 8, 2017). "Medtech lobby says 29,000 jobs were lost while device tax was in effect". MedCity News. Retrieved June 25, 2018.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.